GSK to Buy Canadian Biotech
Wall Street Journal
GSK has reached an agreement to acquire the Canadian late-stage biopharma BELLUS Health for around $2 billion.
https://www.wsj.com/articles/gsk-to-acquire-canadian-bellus-health-for-around-2-bln-93ab3fed